UNOS status of heart transplant patients supported with a left ventricular assist device: Is it time to reconsider the status criteria?

Texas Heart Institute Journal

Volumn 38, Issue 5, 2011, Pages 549-551

  Slaughter, Mark S ^a   Bogaev, Roberta C ^b  

^a University of Louisville School of Medicine   (United States)

^b FACC ^*  (United States)

Author keywords

Left ventricular assist device; Mechanical circulatory support; Transplantation

Indexed keywords

ARTICLE; BLEEDING; CORONARY ARTERY BLOOD FLOW; DEVICE INFECTION; DEVICE SAFETY; HEART ARRHYTHMIA; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; KIDNEY FAILURE; LEFT VENTRICULAR ASSIST DEVICE; PATIENT SAFETY; PATIENT SCHEDULING; POSTOPERATIVE CARE; PRACTICE GUIDELINE; QUALITY OF LIFE; RESPIRATORY FAILURE; SURVIVAL RATE; SURVIVAL TIME; THROMBOEMBOLISM; UNITED NETWORK FOR ORGAN SHARING STATUS CODE 1A;

HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; PATIENT SELECTION; PROSTHESIS DESIGN; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; UNITED STATES; VENTRICULAR FUNCTION, LEFT; WAITING LISTS;

EID: 83455199965     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuous flow left ventricular assist device. N Engl J Med 2009; 361(23):2241-51.
2. Starling RC, Naka Y, Boyle AJ, Gonzalez-Stawinski G, John R, Jorde U, et al. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 2011;57(19):1890-8.
3. Rogers JG, Aaronson KD, Boyle AJ, Russell SD, Milano CA, Pagani FD, et al. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol 2010;55(17):1826-34.
4. John R, Naka Y, Smedira NG, Starling RC, Jorde U, Eckman P, et al. Continuous flow left ventricular assist device outcomes in commercial use compared with the prior clinical trial. Ann Thorac Surg. In press.
5. Williams ML, Trivedi JR, McCants KC, Prabhu SD, Birks EJ, Oliver L, Slaughter MS. Heart transplant vs left ventricular assist device in heart transplant-eligible patients. Ann Tho- rac Surg 2011;91(5):1330-4.